Centre Hospitalier Universitaire De Poitiers

The Service d’oncologie médicale at Centre Hospitalier Universitaire De Poitiers is highly active in oncology, with a strong focus on a wide range of solid tumors and advanced cancers. Research here includes studies aimed at testing new treatment strategies, improving disease control, and comparing emerging therapies with current standards of care.

• Breast, lung, gastrointestinal, and genitourinary cancers
• Rare and difficult-to-treat tumors such as sarcomas, neuroendocrine cancers, and biliary tract cancers
• Trials exploring better treatment effectiveness, recurrence prevention, and personalized cancer care

Much of the work centers on advanced or metastatic disease, reflecting the site’s broad role in evaluating innovative options for patients with limited treatment choices.

Another major research area is hematology, covering both malignant and non-malignant blood disorders. The site contributes to studies in leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and amyloidosis, with the goal of improving survival, reducing symptoms, and refining long-term disease control.

• Acute and chronic leukemias, including acute lymphoblastic leukemia and acute myeloid leukemia
• Lymphomas, multiple myeloma, myelodysplastic syndromes, and myelofibrosis
• Research on treatment effectiveness, transplant-related care, and better supportive approaches

This hematology portfolio shows a strong interest in both newly diagnosed and relapsed disease, including studies designed to improve outcomes in Centre Hospitalier Universitaire De Poitiers patients with complex hematologic conditions.

The site also supports substantial research in cardiovascular disease and related metabolic disorders. Trials address conditions such as myocardial infarction, heart failure, hypertension, atherosclerosis, thrombosis, and diabetes, often with the aim of preventing complications and improving long-term outcomes.

• Acute coronary syndromes, stroke, and other vascular events
• Heart failure, valvular disease, hypertension, and cardiomyopathy
• Studies evaluating prevention strategies, treatment effectiveness, and risk reduction

Research in this area combines acute care and chronic disease management, highlighting the center’s interest in both immediate intervention and long-term cardiovascular protection.

Clinical research at Centre Hospitalier Universitaire De Poitiers extends to immune-mediated diseases, including rheumatology, systemic autoimmune disorders, and inflammatory conditions. These studies aim to improve symptom control, reduce disease activity, and evaluate more targeted treatment options.

• Systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, and juvenile idiopathic arthritis
• Vasculitis, systemic sclerosis, myelitis, and other inflammatory syndromes
• Trials focused on better disease control, safer treatment options, and improved quality of life

This research area reflects a strong commitment to chronic conditions where immune system regulation is central to care.

The site has an active portfolio in respiratory medicine, infectious diseases, and critical care. Research includes severe infections, pneumonia, influenza, chronic lung disease, pulmonary hypertension, and intensive care complications, with a strong emphasis on improving outcomes in hospitalized and critically ill patients.

• COVID-19, sepsis, pneumonia, and bloodstream or postoperative infections
• COPD, asthma, bronchiectasis, pulmonary hypertension, and interstitial lung disease
• Studies testing new ways to treat infection, reduce complications, and support critically ill patients

These trials often address urgent clinical problems where timely treatment and better supportive care can make a major difference.

Beyond its major disease areas, the research environment at this hospital includes neurology, eye diseases, and several other specialized fields. Studies cover Parkinson’s disease, multiple sclerosis, stroke, macular degeneration, and rare neurological or pediatric conditions, often focusing on treatment effectiveness or better disease monitoring.

• Parkinson’s disease, multiple sclerosis, stroke, and traumatic brain injury
• Macular degeneration, diabetic macular edema, and retinoblastoma
• Trials aimed at improving diagnosis, symptom control, and functional outcomes

Across these diverse areas, the site’s research reflects a broad clinical mission that combines innovation in medical oncology with important work in chronic disease management and supportive care.